Neurocrine Biosciences Inc (NBIX)
125.03
+1.74
(+1.41%)
USD |
NASDAQ |
Nov 21, 16:00
123.15
-1.88
(-1.50%)
After-Hours: 20:00
Neurocrine Biosciences Price: 125.03 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 119.36 | 124.01 | 118.91 | 123.29 | 1.404M |
| Nov 19, 2024 | 116.34 | 119.79 | 115.27 | 119.13 | 1.093M |
| Nov 18, 2024 | 117.46 | 118.32 | 116.33 | 117.62 | 1.045M |
| Nov 15, 2024 | 122.10 | 122.69 | 117.36 | 117.44 | 1.255M |
| Nov 14, 2024 | 125.53 | 125.89 | 122.58 | 122.88 | 876531.0 |
| Nov 13, 2024 | 127.19 | 127.84 | 125.51 | 125.51 | 807397.0 |
| Nov 12, 2024 | 126.95 | 128.24 | 126.39 | 127.01 | 893313.0 |
| Nov 11, 2024 | 125.76 | 129.67 | 125.75 | 127.17 | 1.268M |
| Nov 08, 2024 | 124.91 | 126.28 | 123.76 | 125.74 | 561776.0 |
| Nov 07, 2024 | 125.29 | 126.65 | 123.50 | 123.98 | 755193.0 |
| Nov 06, 2024 | 124.10 | 126.48 | 122.47 | 125.30 | 1.215M |
| Nov 05, 2024 | 120.01 | 122.00 | 119.08 | 121.53 | 748298.0 |
| Nov 04, 2024 | 121.27 | 122.32 | 119.70 | 120.53 | 1.019M |
| Nov 01, 2024 | 120.52 | 123.00 | 120.52 | 122.21 | 1.512M |
| Oct 31, 2024 | 122.52 | 123.04 | 119.42 | 120.27 | 1.363M |
| Oct 30, 2024 | 126.46 | 131.26 | 124.15 | 124.33 | 2.596M |
| Oct 29, 2024 | 115.79 | 116.86 | 115.08 | 116.19 | 1.137M |
| Oct 28, 2024 | 115.81 | 117.94 | 115.81 | 116.20 | 676278.0 |
| Oct 25, 2024 | 115.69 | 117.41 | 113.88 | 116.08 | 1.010M |
| Oct 24, 2024 | 115.55 | 117.57 | 114.45 | 115.52 | 797395.0 |
| Oct 23, 2024 | 116.37 | 116.69 | 114.55 | 115.08 | 581975.0 |
| Oct 22, 2024 | 115.68 | 117.20 | 115.68 | 116.78 | 576884.0 |
| Oct 21, 2024 | 117.34 | 117.89 | 116.14 | 116.57 | 550819.0 |
| Oct 18, 2024 | 118.06 | 119.11 | 117.41 | 118.01 | 1.006M |
| Oct 17, 2024 | 118.73 | 119.07 | 118.03 | 118.46 | 728016.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
72.45
Minimum
Jan 27 2022
153.15
Maximum
Aug 01 2024
107.63
Average
104.01
Median
Price Benchmarks
| Repligen Corp | 141.70 |
| West Pharmaceutical Services Inc | 320.95 |
| Bruker Corp | 56.24 |
| The Cooper Companies Inc | 99.91 |
| Integra Lifesciences Holdings Corp | 22.99 |
Price Related Metrics
| PE Ratio | 33.52 |
| PS Ratio | 5.770 |
| PEG Ratio | 0.3334 |
| Price to Book Value | 4.656 |
| Price to Free Cash Flow | 29.40 |
| Earnings Yield | 2.98% |
| Market Cap | 12.66B |
| PEGY Ratio | 0.3334 |
| Operating PE Ratio | 22.00 |
| Normalized PE Ratio | 39.52 |